|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cramer JD, Burtness B, Le QT and Ferris
RL: The changing therapeutic landscape of head and neck cancer. Nat
Rev Clin Oncol. 16:669–683. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pulte D and Brenner H: Changes in survival
in head and neck cancers in the late 20th and early 21st century: A
period analysis. Oncologist. 15:994–1001. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gonzalez-Garcia R, Naval-Gias L,
Roman-Romero L, Sastre-Perez J and Rodriguez-Campo FJ: Local
recurrences and second primary tumors from squamous cell carcinoma
of the oral cavity: A retrospective analytic study of 500 patients.
Head Neck. 31:1168–1180. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pisani P, Airoldi M, Allais A, Valletti
PA, Battista M, Benazzo M, Briatore R, Cacciola S, Cocuzza S,
Colombo A, et al: Metastatic disease in head & neck oncology.
Acta Otorhinolaryngol Ital. 40:S1–S86. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Vermorken JB, Mesia R, Rivera F, Remenar
E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol
D, et al: Platinum-based chemotherapy plus cetuximab in head and
neck cancer. N Engl J Med. 359:1116–1127. 2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Price KA and Cohen EE: Current treatment
options for metastatic head and neck cancer. Curr Treat Options
Oncol. 13:35–46. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R,
Hammond EH, Fu KK and Milas L: Impact of epidermal growth factor
receptor expression on survival and pattern of relapse in patients
with advanced head and neck carcinoma. Cancer Res. 62:7350–7356.
2002.PubMed/NCBI
|
|
9
|
Bonner JA, Harari PM, Giralt J, Azarnia N,
Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, et al:
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head
and neck. N Engl J Med. 354:567–578. 2006.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Han Y, Liu D and Li L: PD-1/PD-L1 pathway:
Current researches in cancer. Am J Cancer Res. 10:727–742.
2020.PubMed/NCBI
|
|
11
|
Ferris RL, Blumenschein G Jr, Fayette J,
Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE,
Even C, et al: Nivolumab for recurrent squamous-cell carcinoma of
the head and neck. N Engl J Med. 375:1856–1867. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cohen EEW, Soulieres D, Le Tourneau C,
Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R,
et al: Pembrolizumab versus methotrexate, docetaxel, or cetuximab
for recurrent or metastatic head-and-neck squamous cell carcinoma
(KEYNOTE-040): A randomised, open-label, phase 3 study. Lancet.
393:156–167. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Haslam A and Prasad V: Estimation of the
percentage of us patients with cancer who are eligible for and
respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw
Open. 2(e192535)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xu N, Tian H, Fung CP, Lin Y, Zhu G, Shen
Y and Yang H: Quantitative evaluation and comparison of two
prodrug-activating suicide gene therapies on oral squamous cell
carcinoma. Am J Cancer Res. 11:1672–1682. 2021.PubMed/NCBI
|
|
15
|
Momose F, Araida T, Negishi A, Ichijo H,
Shioda S and Sasaki S: Variant sublines with different metastatic
potentials selected in nude mice from human oral squamous cell
carcinomas. J Oral Pathol Med. 18:391–395. 1989.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sugiyama M, Bhawal UK, Dohmen T, Ono S,
Miyauchi M and Ishikawa T: Detection of human papillomavirus-16 and
HPV-18 DNA in normal, dysplastic, and malignant oral epithelium.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 95:594–600.
2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Matsui T, Ota T, Ueda Y, Tanino M and
Odashima S: Isolation of a highly metastatic cell line to lymph
node in human oral squamous cell carcinoma by orthotopic
implantation in nude mice. Oral Oncol. 34:253–256. 1998.PubMed/NCBI
|
|
18
|
Karjoo Z, Chen X and Hatefi A: Progress
and problems with the use of suicide genes for targeted cancer
therapy. Adv Drug Deliv Rev. 99:113–128. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bali A, Bali D and Sharma A: An overview
of gene therapy in head and neck cancer. Indian J Hum Genet.
19:282–290. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bairoch A: The cellosaurus, a cell-line
knowledge resource. J Biomol Tech. 29:25–38. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kondo S and Aso K: Establishment of a cell
line of human skin squamous cell carcinoma in vitro. Br J Dermatol.
105:125–132. 1981.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Eagle H: Propagation in a fluid medium of
a human epidermoid carcinoma, strain KB. Proc Soc Exp Biol Med.
89:362–364. 1955.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Horikoshi M, Kimura Y, Nagura H, Ono T and
Ito H: A new human cell line derived from human carcinoma of the
gingiva. I. Its establishment and morphological studies. Nihon Koku
Geka Gakkai Zasshi. 20:100–106. 1974.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
24
|
Takahashi K, Kanazawa H, Akiyama Y, Tazaki
S, Takahara M, Muto T, Tanzawa H and Sato KI: Establishment and
characterization of a cell line (SAS) from poorly differentiated
human squamous cell carcinoma of the tongue. J Jpn Stomatol Soc.
38:20–28. 1989.
|
|
25
|
Cong L, Ran FA, Cox D, Lin S, Barretto R,
Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA and Zhang F:
Multiplex genome engineering using CRISPR/Cas systems. Science.
339:819–823. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pirkmajer S and Chibalin AV: Serum
starvation: Caveat emptor. Am J Physiol Cell Physiol.
301:C272–C279. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yarrow JC, Perlman ZE, Westwood NJ and
Mitchison TJ: A high-throughput cell migration assay using scratch
wound healing, a comparison of image-based readout methods. BMC
Biotechnol. 4(21)2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jonkman JE, Cathcart JA, Xu F, Bartolini
ME, Amon JE, Stevens KM and Colarusso P: An introduction to the
wound healing assay using live-cell microscopy. Cell Adh Migr.
8:440–451. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fischer U, Steffens S, Frank S, Rainov NG,
Schulze-Osthoff K and Kramm CM: Mechanisms of thymidine
kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide
gene therapy-induced cell death in glioma cells. Oncogene.
24:1231–1243. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gao J, Yan Q, Liu S and Yang X: Knockdown
of EpCAM enhances the chemosensitivity of breast cancer cells to
5-fluorouracil by downregulating the antiapoptotic factor Bcl-2.
PLoS One. 9(e102590)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liang L, Bi W, Chen W, Lin Y and Tian Y:
Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate
cancer. Lasers Med Sci. 33:227–232. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bonneton C, Sibarita JB and Thiery JP:
Relationship between cell migration and cell cycle during the
initiation of epithelial to fibroblastoid transition. Cell Motil
Cytoskeleton. 43:288–295. 1999.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pulley JM, Jerome RN, Ogletree ML, Bernard
GR, Lavieri RR, Zaleski NM, Hong CC, Shirey-Rice JK, Arteaga CL,
Mayer IA, et al: Motivation for launching a cancer metastasis
inhibition (CMI) program. Target Oncol. 13:61–68. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Eccles SA and Welch DR: Metastasis: Recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Irion S, Luche H, Gadue P, Fehling HJ,
Kennedy M and Keller G: Identification and targeting of the ROSA26
locus in human embryonic stem cells. Nat Biotechnol. 25:1477–1482.
2007.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ribeiro IP, Rodrigues JM, Mascarenhas A,
Kosyakova N, Caramelo F, Liehr T, Melo JB and Carreira IM:
Cytogenetic, genomic, and epigenetic characterization of the HSC-3
tongue cell line with lymph node metastasis. J Oral Sci. 60:70–81.
2018.PubMed/NCBI View Article : Google Scholar
|
